SV Life Sciences Promotes Darren Black to Partner

Recognizes Strong Contribution to Healthcare IT and Healthcare Services Team

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--SV Life Sciences Advisers, LLC (“SVLS”) today announced the promotion of Darren Black to Partner. Mr. Black, a Principal of SVLS since 2003, is focused on healthcare service, pharmaceutical service and medical device investments.

“Darren has established himself as a productive and creative venture capitalist, expanding the SV Life Sciences service business franchise, especially in the growth area of pharmaceutical service outsourcing”

“Darren has established himself as a productive and creative venture capitalist, expanding the SV Life Sciences service business franchise, especially in the growth area of pharmaceutical service outsourcing,” said Eugene Hill, SVLS Managing Partner specializing in Healthcare IT and Healthcare Services.

Mr. Black currently serves on the board of directors of Allegiance Hospice, CRI Worldwide, Vitalize, and Ricerca Biosciences and is an observer to Accelecare Wound Centers, Aquesys, Cardiofocus, Medifacts International, Osteolign, Socios Mayores en Salud, and US Renal Care.

Before joining SVLS, Darren was Co-Founder and President of two companies: ClinCare, a venture-backed site management organization and PharmaStar (sold to United BioSource Corporation), a central nervous system education services company focused on pharmaceutical companies. Earlier in his career, he was a healthcare consultant for Accenture, assisting managed care and provider-based clients on strategy formulation and implementation.

About SV Life Sciences

SV Life Sciences Advisers, LLC (“SVLS”) is a life sciences-focused venture capital adviser and manager. SVLS advised or managed funds that invest in companies requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services. SVLS advises or manages four venture capital funds and a publicly traded investment trust with total capital of approximately $1.6 billion that invest in life sciences companies at all stages of development. SVLS has 28 professionals and has invested in over 175 companies over the course of the last decade making SVLS one of the largest and most active healthcare investors in the world. SVLS was established in 1993 and currently has offices in Boston, San Francisco and London. For more information, please visit the company’s website at http://www.svlsa.com.